Friday 6 November 2026 Export STE’s income statement to Excel — free account

STERIS plc

STE Healthcare Medical Devices

STERIS plc’s revenue for fiscal 2026 (year ended March 2026) was $5.9 billion, up 8.73% from fiscal 2025.

Revenue: +8.79%
EPS: +12.8%
Free cash flow: +43.6%
Total debt: −0.21%

Quarter to September 2026, against a year earlier

253.25 0.87 −0.34%

Follow STE

Alert me

Market cap: $24.8B
P/E: 30.0×
Fwd P/E: 25.1×
Dividend yield: 1.02%
F-score: 9/9
Altman Z: 5.10
Beneish M: −2.68
Dividend safety: 86/100

Overview Business Profile Earnings & Analysis Valuation Filings

STERIS plc (STE) Price to free cash flow

Alert me on Price to free cash flow

As of 5 November 2026, STERIS plc (STE) trades at a price to free cash flow of 26.4×. Over the past ten years it has ranged from 13.8× (June 2015) to 61.8× (April 2022); the current reading is higher than 22% of that period. That is below the Medical Devices industry median of 28.8× and above the Healthcare sector median of 21.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/STE/price-to-free-cash-flow" width="100%" height="360" style="border:0" loading="lazy" title="STERIS plc price to free cash flow, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/STE/metrics/price-to-free-cash-flow">STERIS plc (STE) price to free cash flow — stockrow.com</a></p>

Period	Price to free cash flow	Change
FY2026	22.1×	(22.18%)
FY2025	28.4×	(19.35%)
FY2024	35.2×	(24.41%)
FY2023	46.6×	(21.21%)
FY2022	59.1×	64.22%
FY2021	36.0×	15.31%
FY2020	31.2×	2.91%
FY2019	30.3×	15.32%
FY2018	26.3×	13.42%
FY2017	23.2×	(40.40%)

Period	Price to free cash flow	Change
Sep 2026	21.8×	(0.70%)
Jun 2026	22.0×	(0.62%)
Mar 2026	22.1×	(16.88%)
Dec 2025	26.6×	5.93%
43 more quarters	Free account

Against its own ten years

Low 13.8× High 61.8×

Ten-year median 31.8×

Current reading's percentile 22

Company	Price to free cash flow
SNN Smith & Nephew SNATS, Inc. compare	7.1×
PHG Koninklijke Philips N.V. compare	14.1×
GMED Globus Medical, Inc. compare	14.5×
ZBH Zimmer Biomet Holdings, Inc. compare	18.2×
GEHC GE HealthCare Technologies Inc. compare	19.9×
STE STERIS plc	26.4×
DXCM DexCom, Inc. compare	28.8×
PEN Penumbra, Inc. compare	63.1×
GKOS Glaukos Corporation compare	360×
Medical Devices industry median	28.8×
Healthcare sector median	21.1×
Market median	14.1×

What Price to free cash flow is

Price to Free Cash Flow Ratio shows how much investors pay for each dollar of cash a company generates after its capital spending.

Stock Price ÷ ((Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM)) ÷ (Shares (Basic, Weighted) (latest quarter)))

The full definition of Price to free cash flow →

STERIS plc (STE) Price to free cash flow

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on STE

Price to free cash flow, daily

Annual newest first

Quarterly newest first

Against its own ten years

Price to free cash flow against peers

What Price to free cash flow is

More on STE

Stockrow Weekly